Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has received final approval by the United States Food & Drug Administration (FDA) for topiramate capsules USP, ...

The agreement is to acquire topiramate HCl 25, 50, 100 and 200 mg tablets for an undisclosed amount. Topiramate is indicated as a treatment of epilepsy and migraine and its market size in the USA was ...

Topiramate 25-mg tablets were used in whole or part, up to doses of 100 mg/day. On reaching this dose, patients then used 50-mg tablets twice daily. All subjects were required to contact the ...